[1]
2026. The Role of Soluble Tumor Necrosis Factor Receptor II as a Prognostic Marker in Severe  COVID-19. Medical Forum Monthly. 37, 9 (Oct. 2026). DOI:https://doi.org/10.60110/medforum.370917.